Pay in 4 interest-free payments of $40.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Valrubicin in combination with radiation enhances the cytotoxicity
is a quinolone-derived sphingomyelin synthase inhibitor that blocks P-glycoprotein and multidrug resistance-associated protein-1
Smiles: CC1=CC=C(C=C1NC1=CC2NC(=O)/C(=C\C3=CC=CN3)/C=2C=C1)NC(=O)NC1=CC(=CC=C1F)C(F)(F)F
glucocorticoid
Double-blind study of pardoprunox
NV-5138 C AR Degrader-4 TFA Valrubicin in combination with radiationNV 5138 is an orally and centrally active small molecule drug for the treatment of major depressive disorder (MDD). It directly and selectively activates the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway by binding to and modulating sestrin2, a leucine amino acid sensor and upstream regulatory pathway. The mTORC1 pathway is the same signaling pathway that the NMDA receptor antagonist ketamine activates in the medial prefrontal
US$ 45.00
US$ 115.00
US$ 75.00
US$ 125.00
US$ 163.00
US$ 157.00